Oct 5, 2026 06:24AM
Sep 14, 2026 09:40AM
Sep 11, 2026 07:05AM
Aug 19, 2026 05:31AM
Aug 6, 2026 01:39PM
Aug 5, 2026 04:10PM
Aug 3, 2026 04:27AM Exelixis (EXEL) Reiterated at Market Outperform by Citizens Amid Handa Patent Suit
Aug 3, 2026 04:22AM
Jul 22, 2026 04:15AM
Jul 2, 2026 08:45AM
Jul 2, 2026 06:42AM
Jun 25, 2026 06:17AM
Jun 24, 2026 04:09AM
Jun 22, 2026 12:29PM Morgan Stanley on Exelixis (EXEL): today's update 'mixed-to-negative at the margin'
May 5, 2026 04:20PM
Apr 21, 2026 09:44AM
Feb 12, 2026 07:11AM
Feb 11, 2026 05:22AM
Feb 10, 2026 04:12PM
Feb 4, 2026 07:08AM
Feb 2, 2026 08:03AM FDA accepts Exelixis drug application for colorectal cancer treatment
Jan 27, 2026 07:06AM
Jan 14, 2026 08:56AM
Jan 14, 2026 04:48AM
Jan 12, 2026 08:28AM
Jan 12, 2026 04:05AM
Jan 8, 2026 03:36AM
Jan 5, 2026 06:19AM BofA Securities Downgrades Exelixis (EXEL) to Underperform
Dec 18, 2025 04:29AM
Dec 11, 2025 07:42AM
Nov 17, 2025 04:12PM
Nov 5, 2025 01:55AM
Nov 4, 2025 04:27PM
Nov 4, 2025 04:17PM
Oct 21, 2025 05:33AM Exelixis (EXEL) PT Lowered to $30 at Wells Fargo
Oct 21, 2025 04:09AM
Oct 20, 2025 08:27AM
Oct 14, 2025 07:29AM
Oct 7, 2025 03:02PM
Sep 22, 2025 09:33AM
Sep 19, 2025 04:06AM
Sep 17, 2025 02:27AM Goldman Sachs Starts Exelixis (EXEL) at Buy
Aug 12, 2025 06:40AM
Jul 29, 2025 09:20AM
Jul 29, 2025 09:02AM
Jul 29, 2025 08:46AM
Jul 29, 2025 04:57AM
Jul 28, 2025 04:57PM
Jul 28, 2025 04:09PM Exelixis (EXEL) Tops Q2 EPS by 11c, provides guidance
Jul 24, 2025 05:04PM

466,339 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All